Published in J Exp Med on December 31, 2007
The biology of intestinal immunoglobulin A responses. Immunity (2008) 3.18
Secretory IgA's complex roles in immunity and mucosal homeostasis in the gut. Mucosal Immunol (2011) 2.26
Between celiac disease and irritable bowel syndrome: the "no man's land" of gluten sensitivity. Am J Gastroenterol (2009) 2.02
Celiac disease: prevalence, diagnosis, pathogenesis and treatment. World J Gastroenterol (2012) 1.99
Tissue-mediated control of immunopathology in coeliac disease. Nat Rev Immunol (2009) 1.91
Celiac disease. Curr Opin Gastroenterol (2010) 1.51
Large Gliadin Peptides Detected in the Pancreas of NOD and Healthy Mice following Oral Administration. J Diabetes Res (2016) 1.38
Celiac disease: how complicated can it get? Immunogenetics (2010) 1.34
Polymeric IgA1 controls erythroblast proliferation and accelerates erythropoiesis recovery in anemia. Nat Med (2011) 1.09
Glycosylation of IgA1 and pathogenesis of IgA nephropathy. Semin Immunopathol (2012) 1.09
Probiotics, prebiotics and immunomodulation of gut mucosal defences: homeostasis and immunopathology. Nutrients (2013) 1.08
Transglutaminase is essential for IgA nephropathy development acting through IgA receptors. J Exp Med (2012) 1.08
Host responses to intestinal microbial antigens in gluten-sensitive mice. PLoS One (2009) 1.08
Pathophysiology of celiac disease. Gastrointest Endosc Clin N Am (2012) 1.05
A randomized, double-blind study of larazotide acetate to prevent the activation of celiac disease during gluten challenge. Am J Gastroenterol (2012) 1.05
New developments in the genetics, pathogenesis, and therapy of IgA nephropathy. Kidney Int (2015) 1.04
Association between maternal iron supplementation during pregnancy and risk of celiac disease in children. Clin Gastroenterol Hepatol (2013) 1.01
Antigen presentation in celiac disease. Curr Opin Immunol (2009) 0.98
Antibodies in celiac disease: implications beyond diagnostics. Cell Mol Immunol (2011) 0.98
Role of transglutaminase 2 in celiac disease pathogenesis. Semin Immunopathol (2012) 0.98
Gliadin peptide P31-43 localises to endocytic vesicles and interferes with their maturation. PLoS One (2010) 0.96
Dectin-1 is essential for reverse transcytosis of glycosylated SIgA-antigen complexes by intestinal M cells. PLoS Biol (2013) 0.95
Potentiation of polarized intestinal Caco-2 cell responsiveness to probiotics complexed with secretory IgA. J Biol Chem (2010) 0.93
Noncanonical role of transferrin receptor 1 is essential for intestinal homeostasis. Proc Natl Acad Sci U S A (2015) 0.93
Celiac disease and non-celiac gluten sensitivity. BMJ (2015) 0.93
Noninflammatory gluten peptide analogs as biomarkers for celiac sprue. Chem Biol (2009) 0.91
Immune development and intestinal microbiota in celiac disease. Clin Dev Immunol (2012) 0.90
The mucosa-kidney axis in IgA nephropathy. Nat Rev Nephrol (2015) 0.89
Targeted modification of wheat grain protein to reduce the content of celiac causing epitopes. Funct Integr Genomics (2012) 0.88
Interferon-gamma released by gluten-stimulated celiac disease-specific intestinal T cells enhances the transepithelial flux of gluten peptides. J Pharmacol Exp Ther (2009) 0.88
Role of IgA and IgA fc receptors in inflammation. J Clin Immunol (2009) 0.87
The potential utility of tight junction regulation in celiac disease: focus on larazotide acetate. Therap Adv Gastroenterol (2016) 0.86
Lessons from rodent models in celiac disease. Mucosal Immunol (2014) 0.85
Epithelial transport and deamidation of gliadin peptides: a role for coeliac disease patient immunoglobulin A. Clin Exp Immunol (2011) 0.84
Dysfunctions of the Iga system: a common link between intestinal and renal diseases. Cell Mol Immunol (2011) 0.84
The intestinal B-cell response in celiac disease. Front Immunol (2012) 0.84
HLA genotyping in pediatric celiac disease patients. Bosn J Basic Med Sci (2014) 0.84
Coeliac disease and rheumatoid arthritis: similar mechanisms, different antigens. Nat Rev Rheumatol (2015) 0.83
The Interaction among Microbiota, Immunity, and Genetic and Dietary Factors Is the Condicio Sine Qua Non Celiac Disease Can Develop. J Immunol Res (2015) 0.83
Therapeutic approaches for celiac disease. Best Pract Res Clin Gastroenterol (2015) 0.81
Neonatal CD71+ Erythroid Cells Do Not Modify Murine Sepsis Mortality. J Immunol (2015) 0.81
Role of secretory IgA in the mucosal sensing of commensal bacteria. Gut Microbes (2014) 0.80
Glutamine-Induced Secretion of Intestinal Secretory Immunoglobulin A: A Mechanistic Perspective. Front Immunol (2016) 0.79
Lactobacillus GG restoration of the gliadin induced epithelial barrier disruption: the role of cellular polyamines. BMC Microbiol (2014) 0.79
New and developing therapies for celiac disease. Therap Adv Gastroenterol (2009) 0.79
Nutritional Keys for Intestinal Barrier Modulation. Front Immunol (2015) 0.79
Gene Expression Profiling of Gliadin Effects on Intestinal Epithelial Cells Suggests Novel Non-Enzymatic Functions of Pepsin and Trypsin. PLoS One (2013) 0.78
Responsive population dynamics and wide seeding into the duodenal lamina propria of transglutaminase-2-specific plasma cells in celiac disease. Mucosal Immunol (2015) 0.78
IgA- and SIgA anti-PR3 antibodies in serum versus organ involvement and disease activity in PR3-ANCA-associated vasculitis. Clin Exp Immunol (2016) 0.77
Galactosylation of serum IgA1 O-glycans in celiac disease. J Clin Immunol (2010) 0.77
Rotavirus specific plasma secretory immunoglobulin in children with acute gastroenteritis and children vaccinated with an attenuated human rotavirus vaccine. Hum Vaccin Immunother (2013) 0.76
Celiac anti-type 2 transglutaminase antibodies induce phosphoproteome modification in intestinal epithelial Caco-2 cells. PLoS One (2013) 0.76
Abnormal apical-to-basal transport of dietary ovalbumin by secretory IgA stimulates a mucosal Th1 response. Mucosal Immunol (2013) 0.76
Celiac Disease: Role of the Epithelial Barrier. Cell Mol Gastroenterol Hepatol (2017) 0.75
Umbilical cord CD71+ erythroid cells are reduced in neonates born to women in spontaneous preterm labor. Am J Reprod Immunol (2016) 0.75
Circulating secretory IgA antibodies against cyclic citrullinated peptides in early rheumatoid arthritis associate with inflammatory activity and smoking. Arthritis Res Ther (2016) 0.75
Gliadin-Specific T-Cells Mobilized in the Peripheral Blood of Coeliac Patients by Short Oral Gluten Challenge: Clinical Applications. Nutrients (2015) 0.75
Maternal Immunization: New Perspectives on Its Application Against Non-Infectious Related Diseases in Newborns. Vaccines (Basel) (2017) 0.75
Elevated Total Iron-Binding Capacity Is Associated with an Increased Risk of Celiac Disease. Dig Dis Sci (2015) 0.75
Higher Levels of Secretory IgA Are Associated with Low Disease Activity Index in Patients with Reactive Arthritis and Undifferentiated Spondyloarthritis. Front Immunol (2017) 0.75
Immuno-localization of the insulin regulatable glucose transporter in brown adipose tissue of the rat. J Cell Biol (1991) 8.67
Structural basis for gluten intolerance in celiac sprue. Science (2002) 8.16
Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch Intern Med (2003) 7.80
Prevalence of Celiac disease among children in Finland. N Engl J Med (2003) 7.27
Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. Immunity (2004) 4.36
Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease. Lancet (2003) 3.78
A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease. Immunity (2004) 3.76
The intestinal T cell response to alpha-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase. J Exp Med (2000) 3.73
Rotavirus infection frequency and risk of celiac disease autoimmunity in early childhood: a longitudinal study. Am J Gastroenterol (2006) 3.55
Interleukin 15: a key to disrupted intraepithelial lymphocyte homeostasis and lymphomagenesis in celiac disease. Gastroenterology (2003) 3.05
Transglutaminase is essential in receptor-mediated endocytosis of alpha 2-macroglobulin and polypeptide hormones. Nature (1980) 2.82
Human neonatal Fc receptor mediates transport of IgG into luminal secretions for delivery of antigens to mucosal dendritic cells. Immunity (2004) 2.79
Structural basis for HLA-DQ2-mediated presentation of gluten epitopes in celiac disease. Proc Natl Acad Sci U S A (2004) 2.33
Isolation and characterization of an Fc receptor from neonatal rat small intestine. Eur J Immunol (1985) 2.20
Limited efficiency of prolyl-endopeptidase in the detoxification of gliadin peptides in celiac disease. Gastroenterology (2005) 2.11
IgA Fc receptors. Annu Rev Immunol (2001) 1.98
Intestinal macrophages lack CD14 and CD89 and consequently are down-regulated for LPS- and IgA-mediated activities. J Immunol (2001) 1.95
Wheat peptide challenge in coeliac disease. Lancet (1994) 1.88
Interleukin 15 mediates epithelial changes in celiac disease. Gastroenterology (2000) 1.79
Circulating immune complexes and immunoglobulin A rheumatoid factor in patients with mesangial immunoglobulin A nephropathies. J Clin Invest (1986) 1.70
Dissociation between systemic and mucosal humoral immune responses in coeliac disease. Gut (1991) 1.61
Celiac disease and HLA DQ in patients with IgA nephropathy. Am J Gastroenterol (2002) 1.60
Serologic assay based on gliadin-related nonapeptides as a highly sensitive and specific diagnostic aid in celiac disease. Clin Chem (2004) 1.50
Apical and basolateral endocytic pathways of MDCK cells meet in acidic common endosomes distinct from a nearly-neutral apical recycling endosome. Traffic (2000) 1.49
Definition of the initial immunologic modifications upon in vitro gliadin challenge in the small intestine of celiac patients. Gastroenterology (1996) 1.47
Histological changes in small bowel mucosa induced by gliadin sensitive T lymphocytes can be blocked by anti-interferon gamma antibody. Gut (1995) 1.40
Selective adherence of IgA to murine Peyer's patch M cells: evidence for a novel IgA receptor. J Immunol (2002) 1.39
Identification of the transferrin receptor as a novel immunoglobulin (Ig)A1 receptor and its enhanced expression on mesangial cells in IgA nephropathy. J Exp Med (2001) 1.35
Alterations of the intestinal transport and processing of gliadin peptides in celiac disease. Gastroenterology (2003) 1.33
Glycosylation and size of IgA1 are essential for interaction with mesangial transferrin receptor in IgA nephropathy. J Am Soc Nephrol (2004) 1.33
Antigen presentation to celiac lesion-derived T cells of a 33-mer gliadin peptide naturally formed by gastrointestinal digestion. J Immunol (2004) 1.23
Celiac disease: antibody recognition against native and selectively deamidated gliadin peptides. Clin Chem (2001) 1.22
Regulation of the formation and external transport of secretory immunoglobulins. Crit Rev Immunol (1999) 1.22
Unexpected role of surface transglutaminase type II in celiac disease. Gastroenterology (2005) 1.21
Molecular heterogeneity of Fc alpha receptors detected by receptor-specific monoclonal antibodies. J Immunol (1992) 1.20
A neutralizing monoclonal antibody (mAb A24) directed against the transferrin receptor induces apoptosis of tumor T lymphocytes from ATL patients. Blood (2003) 1.17
Immunofluorescence analysis of IgA binding by human mononuclear cells in blood and lymphoid tissue. J Immunol (1989) 1.13
In vitro toxicity of gluten peptides in coeliac disease assessed by organ culture. Scand J Gastroenterol (1995) 1.09
Intestinal epithelial cells express the CD23/Fc epsilon RII molecule: enhanced expression in enteropathies. Immunology (1993) 1.07
Monoclonal anti-Id antibodies react with varying proportions of human B lineage cells. J Immunol (1987) 1.05
Immunoglobulin G binding sites on the human foetal intestine: a possible mechanism for the passive transfer of immunity from mother to infant. Immunology (1993) 1.03
Enhanced transepithelial antigen transport in intestine of allergic mice is mediated by IgE/CD23 and regulated by interleukin-4. Gastroenterology (2001) 1.02
Targeting of secretory IgA to Peyer's patch dendritic and T cells after transport by intestinal M cells. J Immunol (2004) 1.01
Glomerular IgA deposits in patients with celiac disease. Clin Nephrol (1990) 0.97
The endocytosis of transferrin by rat intestinal epithelial cells. Gastroenterology (1994) 0.96
Serum IgA anti-gliadin antibodies in an adult population sample. High prevalence without celiac disease. Dig Dis Sci (1993) 0.91
Composition of IgA immune complexes precipitated with polyethylene glycol. A model for isolation and analysis of immune complexes. J Immunol Methods (1987) 0.90
Variation of serum and intestinal gluten antibody specificities in coeliac disease. Clin Exp Immunol (1987) 0.90
The establishment of polarity and enhanced transcytosis of transferrin receptors in enterocyte-like Caco-2 cells. J Drug Target (1994) 0.90
Reduced chemokine receptor 9 on intraepithelial lymphocytes in celiac disease suggests persistent epithelial activation. Gastroenterology (2007) 0.90
Immunoglobulin production by coeliac biopsies in organ culture. Gut (1986) 0.87
Gliadin and tissue transglutaminase complexes in normal and coeliac duodenal mucosa. Clin Exp Immunol (2003) 0.87
Food allergens are protected from degradation during CD23-mediated transepithelial transport. Int Arch Allergy Immunol (2004) 0.86
Adaptive changes of duodenal iron transport proteins in celiac disease. Physiol Genomics (2004) 0.84
Secretory immunity in celiac disease: cellular expression of immunoglobulin A subclass and joining chain. Gastroenterology (1990) 0.84
Expression and modulation of the human immunoglobulin A Fc receptor (CD89) and the FcR gamma chain on myeloid cells in blood and tissue. Scand J Immunol (2003) 0.84
IgA antibodies of coeliac disease patients recognise a dominant T cell epitope of A-gliadin. Gut (2004) 0.80
[Serological diagnosis of celiac disease: anti-gliadin peptide antibodies and tissue anti-transglutaminase]. Medicina (B Aires) (1999) 0.78
Jejunal secretion of secretory immunoglobulins and gliadin antibodies in celiac disease. Dig Dis Sci (1992) 0.78
Involvement of membrane-bound transglutaminase in the invagination of transferrin into rat reticulocyte plasma membrane. Biol Pharm Bull (1994) 0.77
Celiac disease. N Engl J Med (2007) 10.98
The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses. Immunity (2009) 8.95
Pneumatic dilation versus laparoscopic Heller's myotomy for idiopathic achalasia. N Engl J Med (2011) 6.76
Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense. Immunity (2008) 6.49
NOX2 controls phagosomal pH to regulate antigen processing during crosspresentation by dendritic cells. Cell (2006) 5.35
Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial. Lancet (2012) 5.12
Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study. Lancet (2009) 5.03
The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide. Science (2013) 4.60
Post-polypectomy colonoscopy surveillance: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy (2013) 4.03
Maintenance of remission among patients with Crohn's disease on antimetabolite therapy after infliximab therapy is stopped. Gastroenterology (2011) 3.81
A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease. Immunity (2004) 3.76
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations. J Crohns Colitis (2009) 3.66
Early administration of azathioprine vs conventional management of Crohn's Disease: a randomized controlled trial. Gastroenterology (2013) 3.45
Outcomes of treatment for achalasia depend on manometric subtype. Gastroenterology (2012) 3.35
Aspirin for the chemoprevention of colorectal adenomas: meta-analysis of the randomized trials. J Natl Cancer Inst (2009) 3.15
Postnatal acquisition of endotoxin tolerance in intestinal epithelial cells. J Exp Med (2006) 3.12
Interleukin 15: a key to disrupted intraepithelial lymphocyte homeostasis and lymphomagenesis in celiac disease. Gastroenterology (2003) 3.05
Daily soluble aspirin and prevention of colorectal adenoma recurrence: one-year results of the APACC trial. Gastroenterology (2003) 2.96
Safety and efficacy of antigen-specific regulatory T-cell therapy for patients with refractory Crohn's disease. Gastroenterology (2012) 2.95
A randomized, double-blind, controlled withdrawal trial in Crohn's disease patients in long-term remission on azathioprine. Gastroenterology (2005) 2.70
Capsule endoscopy or push enteroscopy for first-line exploration of obscure gastrointestinal bleeding? Gastroenterology (2006) 2.54
Incidence of autoimmune diseases in celiac disease: protective effect of the gluten-free diet. Clin Gastroenterol Hepatol (2008) 2.50
Azathioprine withdrawal in patients with Crohn's disease maintained on prolonged remission: a high risk of relapse. Clin Gastroenterol Hepatol (2008) 2.44
Presentation and long-term follow-up of refractory celiac disease: comparison of type I with type II. Gastroenterology (2008) 2.39
Inhibiting glutamine uptake represents an attractive new strategy for treating acute myeloid leukemia. Blood (2013) 2.38
Long-term follow-up of 61 coeliac patients diagnosed in childhood: evolution toward latency is possible on a normal diet. Gut (2007) 2.34
Identification of FcalphaRI as an inhibitory receptor that controls inflammation: dual role of FcRgamma ITAM. Immunity (2005) 2.27
Molecular inventory of faecal microflora in patients with Crohn's disease. FEMS Microbiol Ecol (2004) 2.21
Limited efficiency of prolyl-endopeptidase in the detoxification of gliadin peptides in celiac disease. Gastroenterology (2005) 2.11
Airway fungal colonization compromises the immune system allowing bacterial pneumonia to prevail. Crit Care Med (2013) 2.05
Inhibition of TGF-beta signaling by IL-15: a new role for IL-15 in the loss of immune homeostasis in celiac disease. Gastroenterology (2006) 2.01
Segmental reversal of the small bowel can end permanent parenteral nutrition dependency: an experience of 38 adults with short bowel syndrome. Ann Surg (2012) 2.01
Prospective, randomized comparison of two small-bowel capsule endoscopy systems in patients with obscure GI bleeding. Gastrointest Endosc (2011) 1.99
MHC II in dendritic cells is targeted to lysosomes or T cell-induced exosomes via distinct multivesicular body pathways. Traffic (2009) 1.98
Analysis of ESCRT functions in exosome biogenesis, composition and secretion highlights the heterogeneity of extracellular vesicles. J Cell Sci (2013) 1.98
Prediction of drainage effectiveness during endoscopic stenting of malignant hilar strictures: the role of liver volume assessment. Gastrointest Endosc (2010) 1.91
Fibrin glue is effective healing perianal fistulas in patients with Crohn's disease. Gastroenterology (2010) 1.73
A humanized mouse model of idiopathic nephrotic syndrome suggests a pathogenic role for immature cells. J Am Soc Nephrol (2007) 1.66
Both IgA nephropathy and alcoholic cirrhosis feature abnormally glycosylated IgA1 and soluble CD89-IgA and IgG-IgA complexes: common mechanisms for distinct diseases. Kidney Int (2011) 1.64
Mast cell-mediated remodeling and fibrinolytic activity protect against fatal glomerulonephritis. J Immunol (2006) 1.63
Refractory coeliac disease. Best Pract Res Clin Gastroenterol (2005) 1.61
T84-intestinal epithelial exosomes bear MHC class II/peptide complexes potentiating antigen presentation by dendritic cells. Gastroenterology (2007) 1.60
A Bifidobacterium probiotic strain and its soluble factors alleviate chloride secretion by human intestinal epithelial cells. J Nutr (2009) 1.60
Hsp70 regulates erythropoiesis by preventing caspase-3-mediated cleavage of GATA-1. Nature (2006) 1.59
CD16 promotes Escherichia coli sepsis through an FcR gamma inhibitory pathway that prevents phagocytosis and facilitates inflammation. Nat Med (2007) 1.57
Identification of restricted subsets of mature microRNA abnormally expressed in inactive colonic mucosa of patients with inflammatory bowel disease. PLoS One (2010) 1.54
Sarcopenia predicts early dose-limiting toxicities and pharmacokinetics of sorafenib in patients with hepatocellular carcinoma. PLoS One (2012) 1.53
The enteropathy associated with common variable immunodeficiency: the delineated frontiers with celiac disease. Am J Gastroenterol (2010) 1.50
Erythromycin improves the quality of EGD in patients with acute upper GI bleeding: a randomized controlled study. Gastrointest Endosc (2002) 1.49
In vitro and ex vivo activation of the TLR5 signaling pathway in intestinal epithelial cells by a commensal Escherichia coli strain. J Biol Chem (2004) 1.49
Reliability of antitransglutaminase antibodies as predictors of gluten-free diet compliance in adult celiac disease. Am J Gastroenterol (2003) 1.48
Pediatric ulcerative colitis associated with autoimmune diseases: a distinct form of inflammatory bowel disease? Inflamm Bowel Dis (2012) 1.46
Study of the impact of liver transplantation on the outcome of intestinal grafts in children. Transplantation (2006) 1.44
[Appropiateness of colonoscopy in a gastrointestinal unit in 2001: a prospective study using criteria established by a European panel of experts]. Gastroenterol Clin Biol (2003) 1.44
Identification of the IFITM family as a new molecular marker in human colorectal tumors. Cancer Res (2006) 1.44
Defective IL10 signaling defining a subgroup of patients with inflammatory bowel disease. Am J Gastroenterol (2011) 1.43
A genetic study of the role of the Wnt/beta-catenin signalling in Paneth cell differentiation. Dev Biol (2008) 1.42
CARD15/NOD2 is required for Peyer's patches homeostasis in mice. PLoS One (2007) 1.41
The European experience with double-balloon enteroscopy: indications, methodology, safety, and clinical impact. Gastrointest Endosc (2005) 1.41
Crohn's disease over 20 years after diagnosis in a referral population. Gastroenterol Clin Biol (2004) 1.41
Mucosal-associated invariant T (MAIT) cells: an evolutionarily conserved T cell subset. Microbes Infect (2005) 1.40
Targeting iron homeostasis induces cellular differentiation and synergizes with differentiating agents in acute myeloid leukemia. J Exp Med (2010) 1.39
The LKB1/AMPK signaling pathway has tumor suppressor activity in acute myeloid leukemia through the repression of mTOR-dependent oncogenic mRNA translation. Blood (2010) 1.38
Calcium supplementation for preventing colorectal cancer: where do we stand? Lancet (2004) 1.38
Identification and structural basis of the reaction catalyzed by CYP121, an essential cytochrome P450 in Mycobacterium tuberculosis. Proc Natl Acad Sci U S A (2009) 1.38
CT, endoscopic sonography, and a combined protocol for preoperative evaluation of pancreatic insulinomas. AJR Am J Roentgenol (2003) 1.38
A bacterial enzyme to treat celiac disease? J Pediatr Gastroenterol Nutr (2003) 1.38
Dissecting the genetic components of adaptation of Escherichia coli to the mouse gut. PLoS Genet (2007) 1.37
Alterations of the intestinal transport and processing of gliadin peptides in celiac disease. Gastroenterology (2003) 1.33
Glycosylation and size of IgA1 are essential for interaction with mesangial transferrin receptor in IgA nephropathy. J Am Soc Nephrol (2004) 1.33
Celiac disease: an immunological jigsaw. Immunity (2012) 1.33
Nodular regenerative hyperplasia: the main liver disease in patients with primary hypogammaglobulinemia and hepatic abnormalities. J Hepatol (2007) 1.31
Sialorphin, a natural inhibitor of rat membrane-bound neutral endopeptidase that displays analgesic activity. Proc Natl Acad Sci U S A (2003) 1.28
N-terminal domains elicit formation of functional Pmel17 amyloid fibrils. J Biol Chem (2009) 1.28